Dominique de Souza Farias

Dominique de Souza Farias

Auto-generated profile, based on publicly available information

Dominique de Souza Farias

Centro Universitário Estácio

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2023 in Research, Society and Development
Verified
Journal Article
Open access
PDF file
ISIsaias Sena Moraes de Souza
Isaias Sena Moraes de Souza
LPLaura Maria de Araújo Pereira
Laura Maria de Araújo Pereira
SNSenyra Maria das Neves
Senyra Maria das Neves
DFDominique de Souza Farias
Dominique de Souza Farias
JIJemima Silva Inocêncio
Jemima Silva Inocêncio
JJJosé Guedes da Silva Júnior
José Guedes da Silva Júnior
The present work performs an integrative review of the literature on schistosomiasis in Brazil, a parasitic and waterborne disease caused by flatworms of the genus Schistosoma (S. mansoni; S. japonicum; S. haematobium), and which still manifests itself as a problem significant public health problem in this country. It aims to highlight clinical data, as well as epidemiological data, presenting the most affected regions, individuals most vulnerable to infection and factors associated with its occurrence. In addition, it aims to update the current scenario with regard to the development of a vaccine against the parasites that cause schistosomiasis. The study carried out analyzes in the PubMed and Latin American and Caribbean Literature in Health Sciences (LILACS), ScienceDirect databases, as well as using data from the World Health Organization (WHO), the Centers For Disease Control and Prevention (CDC) and the Ministry of Health of Brazil (MS). It is concluded that schistosomiasis remains a disease of high national relevance, since it still manifests itself as a public health problem, responsible for intensifying situations of social inequality and having a direct connection with poverty, as a cause, but also as a consequence of same. Currently, several vaccines are in the clinical trial phase, but none is commercially available, and investment in research is of great importance.